| # | Drug | Count |
|---|---|---|
| 0 | IBRUTINIB | 61 |
| 1 | RISANKIZUMAB-RZAA | 18 |
| 2 | PREDNISONE | 16 |
| 3 | UPADACITINIB | 15 |
| 4 | VENETOCLAX | 15 |
| 5 | ERGOCALCIFEROL | 13 |
| 6 | ASPIRIN | 11 |
| 7 | ASPIRIN 325 MG | 10 |
| 8 | ASPIRIN 81 MG | 10 |
| 9 | ATORVASTATIN CALCIUM | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PSYLLIUM HUSK | 3 | 0.0022 |
| 1 | SODIUM FLUORIDE AND POTASSIUM NITRATE | 2 | 0.0019 |
| 2 | AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE | 1 | 0.0015 |
| 3 | CHROMIC CHLORIDE | 1 | 0.0012 |
| 4 | OXAPROZIN | 1 | 0.0011 |
| 5 | CEMIPLIMAB-RWLC | 2 | 0.0010 |
| 6 | ANTIHEMOPHILIC FACTOR/VON WILLEBRAND FACTOR COMPLEX (HUMAN) | 1 | 0.0009 |
| 7 | MECHLORETHAMINE HYDROCHLORIDE | 2 | 0.0009 |
| 8 | INFLIXIMAB-DYYB | 3 | 0.0009 |
| 9 | CICLOPIROX | 2 | 0.0008 |
| # | Drug class | Count |
|---|---|---|
| 0 | Kinase Inhibitor [EPC] | 65 |
| 1 | Corticosteroid [EPC] | 23 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 19 |
| 3 | Interleukin-23 Antagonist [EPC] | 18 |
| 4 | Janus Kinase Inhibitor [EPC] | 17 |
| 5 | BCL-2 Inhibitor [EPC] | 15 |
| 6 | Tumor Necrosis Factor Blocker [EPC] | 15 |
| 7 | Provitamin D2 Compound [EPC] | 13 |
| 8 | Vitamin C [EPC] | 13 |
| 9 | HMG-CoA Reductase Inhibitor [EPC] | 12 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 1 | alpha-Hydroxy Acid [EPC] | 1 | 0.0005 |
| 2 | Neonatal Fc Receptor Blocker [EPC] | 2 | 0.0005 |
| 3 | Provitamin D2 Compound [EPC] | 13 | 0.0004 |
| 4 | RNA Synthetase Inhibitor Antibacterial [EPC] | 4 | 0.0003 |
| 5 | Ectoparasiticide [EPC] | 1 | 0.0003 |
| 6 | BCL-2 Inhibitor [EPC] | 15 | 0.0002 |
| 7 | Blood Viscosity Reducer [EPC] | 1 | 0.0002 |
| 8 | Interleukin-23 Antagonist [EPC] | 18 | 0.0002 |
| 9 | Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] | 1 | 0.0002 |